Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Nokia | 1.41% | $18.47M | $36.26B | 45.43% | 66 Neutral | |
| Roche Holding AG | 1.16% | $15.26M | CHF259.92B | 52.00% | 73 Outperform | |
| Toronto Dominion Bank | 1.14% | $15.01M | $158.09B | 77.36% | 74 Outperform | |
| Engie SA | 1.13% | $14.89M | €53.49B | 47.46% | 64 Neutral | |
| GlaxoSmithKline | 1.13% | $14.85M | $98.80B | 43.55% | 77 Outperform | |
| Royal Bank Of Canada | 1.08% | $14.13M | $239.11B | 41.55% | 75 Outperform | |
| BOC Hong Kong (Holdings) | 1.02% | $13.40M | HK$412.13B | 59.46% | 78 Outperform | |
| Novartis AG | 1.00% | $13.15M | CHF206.92B | 25.57% | 80 Outperform | |
| Fairfax Financial Holdings | 1.00% | $13.10M | $43.91B | 34.48% | 81 Outperform | |
| Bank Of Montreal | 0.98% | $12.85M | C$126.51B | 34.58% | 74 Outperform |